denkapparat Operations GmbH bought a new stake in Corteva, Inc. (NYSE:CTVA – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 7,820 shares of the company’s stock, valued at approximately $529,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of CTVA. Norges Bank bought a new stake in Corteva in the second quarter valued at approximately $434,220,000. Pacer Advisors Inc. lifted its holdings in Corteva by 4,007.1% during the 3rd quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock valued at $165,164,000 after purchasing an additional 2,382,715 shares during the last quarter. Marshall Wace LLP boosted its position in Corteva by 1,365.9% during the second quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock worth $134,882,000 after purchasing an additional 1,686,309 shares during the period. National Pension Service increased its holdings in shares of Corteva by 148.4% in the second quarter. National Pension Service now owns 2,454,601 shares of the company’s stock valued at $182,941,000 after purchasing an additional 1,466,268 shares during the last quarter. Finally, Qube Research & Technologies Ltd increased its holdings in shares of Corteva by 566.0% in the second quarter. Qube Research & Technologies Ltd now owns 1,247,120 shares of the company’s stock valued at $92,948,000 after purchasing an additional 1,059,872 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts recently commented on CTVA shares. Wall Street Zen downgraded shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. JPMorgan Chase & Co. cut Corteva from an “overweight” rating to a “neutral” rating and boosted their price objective for the stock from $75.00 to $77.00 in a report on Thursday, February 5th. CICC Research increased their target price on Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 11th. Citigroup boosted their price target on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and an average target price of $82.20.
Corteva Price Performance
Shares of NYSE CTVA opened at $74.98 on Monday. The business has a fifty day moving average price of $69.67 and a two-hundred day moving average price of $68.41. The stock has a market capitalization of $50.43 billion, a PE ratio of 47.46, a P/E/G ratio of 2.56 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $77.41.
Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. During the same quarter last year, the business earned $0.32 earnings per share. Corteva’s revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.
Corteva Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio is 45.57%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Stories
- Five stocks we like better than Corteva
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- URGENT: Sell this stock immediately
- They just tried to kill gold
- Your Bank Account Is No Longer Safe
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
